Clinical Trials
95 trialsNCT04588246 2026-05-20
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Phase 3 Terminated
NCT04251533 2026-05-11
EPIK-B3
Novartis
Phase 3 Terminated
NCT02525211 2026-04-21
Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment
Institut Paoli-Calmettes
Phase 3 Terminated
NCT01613482 2026-03-16
TSARINE
Centre Oscar Lambret
Phase 3 Terminated
NCT06038539 2026-03-13
Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer
Biocon Limited
Phase 3 Terminated
NCT00210236 2025-10-20
AXIL95
Institut Bergonié
Phase 3 Terminated
NCT03598712 2025-10-06
CLODIS
Centre Francois Baclesse
Phase 3 Terminated
NCT05128773 2025-09-16
AMEERA-6
Sanofi
Phase 3 Terminated
NCT04478266 2025-09-11
AMEERA-5
Sanofi
Phase 3 Terminated
NCT04815083 2025-09-03
Fluorescence Imaging of Carcinoma During Breast Conserving Surgery
SBI ALApharma Canada, Inc.
Phase 3 Terminated
NCT04740918 2025-08-08
KATE3
Hoffmann-La Roche
Phase 3 Terminated
NCT04752332 2025-07-15
eMonarcHER
Eli Lilly and Company
Phase 3 Terminated
NCT00520975 2025-03-28
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
National Cancer Institute (NCI)
Phase 3 Terminated
NCT03936933 2025-02-17
Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients with Breast Cancer
Eurofarma Laboratorios S.A.
Phase 3 Terminated
NCT03498716 2024-08-21
IMpassion030
Hoffmann-La Roche
Phase 3 Terminated
NCT04395339 2024-08-01
GLORY
Sun Yat-sen University
Phase 3 Terminated
NCT05239663 2024-08-01
GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer
Sun Yat-sen University
Phase 3 Terminated
NCT05207514 2024-05-17
Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer
Samyang Biopharmaceuticals Corporation
Phase 3 Terminated
NCT05134194 2024-04-16
A Study of Camrelizumab in Combination With Chemotherapy Regimen Comparative Chemotherapy Regimen for Metastatic Triple-negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3 Terminated
NCT05065411 2024-02-26
VERU-024
Veru Inc.
Phase 3 Terminated
NCT04869943 2024-01-26
ARTEST
Veru Inc.
Phase 3 Terminated
NCT03786094 2023-11-01
FORTRESS
Spexis AG
Phase 3 Terminated
NCT01303679 2023-09-06
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Phase 3 Terminated
NCT04385433 2023-08-24
PRAVAPREV-01
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 3 Terminated
NCT03152929 2023-06-06
Paravertebral Block (PVC) Versus Pectoral Nerve Block (PEC)
Corewell Health West
Phase 3 Terminated
NCT04335006 2023-05-06
A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Terminated
NCT00272987 2023-04-28
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
Novartis
Phase 3 Terminated
NCT00004935 2023-04-18
Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2
Swiss Cancer Institute
Phase 3 Terminated
NCT02927249 2023-04-05
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT02332928 2023-03-30
Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy
Virginia Commonwealth University
Phase 3 Terminated
NCT00543127 2023-03-10
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
Spanish Breast Cancer Research Group
Phase 3 Terminated
NCT01905592 2022-11-15
BRAVO
Tesaro, Inc.
Phase 3 Terminated
NCT02340221 2022-07-12
SANDPIPER
Hoffmann-La Roche
Phase 3 Terminated
NCT01067144 2022-05-05
Stanford Accelerated Recovery Trial (START)
Stanford University
Phase 3 Terminated
NCT01608451 2022-05-02
Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer
Tata Memorial Hospital
Phase 3 Terminated
NCT01077154 2021-09-28
Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)
Amgen
Phase 3 Terminated
NCT00508274 2021-09-21
Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China
Novartis
Phase 3 Terminated
NCT03326674 2021-07-30
CONTESSA
Odonate Therapeutics, Inc.
Phase 3 Terminated
NCT03905343 2021-06-16
Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC
Swiss Cancer Institute
Phase 3 Terminated
NCT00296010 2021-02-23
CASA
ETOP IBCSG Partners Foundation
Phase 3 Terminated
NCT02730091 2021-02-01
VICTORIANE
Centre Hospitalier Universitaire de Besancon
Phase 3 Terminated
NCT02137837 2021-01-28
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
SWOG Cancer Research Network
Phase 3 Terminated
NCT03055312 2021-01-28
SYSUCC-007
Sun Yat-sen University
Phase 3 Terminated
NCT00625898 2020-09-10
BETH
NSABP Foundation Inc
Phase 3 Terminated
NCT03050398 2020-05-28
A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib
Novartis
Phase 3 Terminated
NCT02532400 2020-03-11
COMPETE
Ruijin Hospital
Phase 3 Terminated
NCT02054338 2019-08-28
VICTORIA
Pierre Fabre Medicament
Phase 3 Terminated
NCT00908531 2019-04-29
REAL
Danish Breast Cancer Cooperative Group
Phase 3 Terminated
NCT00130494 2019-04-16
Zoledronic Acid Administration to Metastatic Breast Cancer Patients With Non-symptomatic Bone Lesions
Spanish Breast Cancer Research Group
Phase 3 Terminated
NCT01633060 2019-01-30
BELLE-3
Novartis
Phase 3 Terminated